cross‐validated 11‐protein serum‐plasma risk score with a specific algorithm and found that the expressions of CRP, factor VII, and monocyte chemotactic protein (MCP) were decreased in the body fluids of patients with AD (serum, plasma, and CSF). Here, F7 is linked to Alzheimer disease.